Clinical Trials Directory

Trials / Completed

CompletedNCT01836146

International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Abbott Medical Devices · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this First-in-Human Clinical investigation is to evaluate the safety and performance of the St. Jude Medical EnligHTN™ Generation 2 Renal Denervation System for the treatment of patients with drug-resistant uncontrolled hypertension.

Conditions

Interventions

TypeNameDescription
DEVICEEnligHTN™ Renal Artery Ablation Catheter

Timeline

Start date
2013-04-01
Primary completion
2014-03-01
Completion
2015-09-01
First posted
2013-04-19
Last updated
2019-02-04

Locations

6 sites across 2 countries: Australia, New Zealand

Source: ClinicalTrials.gov record NCT01836146. Inclusion in this directory is not an endorsement.